• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性炎症性皮肤病中炎症驱动的分子衰老:生物疗法有作用吗?

Inflammation-Driven Molecular Ageing in Chronic Inflammatory Skin Diseases: Is There a Role for Biologic Therapies?

作者信息

Andrzejczak Klara, Sternak Agata, Witkowski Wiktor, Ponikowska Małgorzata

机构信息

Faculty of Medicine, Wroclaw Medical University, Wybrzeze L. Pasteura 1, 50-367 Wroclaw, Poland.

Student Research Group of Experimental Dermatology, University Centre of General Dermatology and Oncodermatology, Wroclaw Medical University, 50-556 Wroclaw, Poland.

出版信息

Cells. 2025 Sep 15;14(18):1442. doi: 10.3390/cells14181442.

DOI:10.3390/cells14181442
PMID:41002407
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12469205/
Abstract

Chronic inflammatory skin diseases such as atopic dermatitis, psoriasis, and hidradenitis suppurativa are systemic conditions marked by persistent immune activation. Growing evidence links them to molecular and vascular ageing, including oxidative stress, endothelial dysfunction, and reduced expression of longevity-related proteins like Klotho and SIRT1. This narrative review examines how Th17- and Th2-driven inflammation contributes to systemic inflammageing. Key cytokines-IL-17, IL-23, IL-4, IL-13, and IL-31-promote endothelial damage, oxidative stress, and metabolic dysfunction. We highlight the role of vascular biomarkers (e.g., VCAM-1, ICAM-1, ST2, P-selectin) and immune cell senescence as indicators of ageing. Finally, we explore whether biologic therapies targeting these pathways may attenuate inflammation-driven ageing. Chronic skin diseases may thus serve as accessible models of systemic inflammageing and targets for early intervention.

摘要

特应性皮炎、银屑病和化脓性汗腺炎等慢性炎症性皮肤病是由持续免疫激活所标记的全身性疾病。越来越多的证据将它们与分子和血管衰老联系起来,包括氧化应激、内皮功能障碍以及诸如Klotho和SIRT1等长寿相关蛋白表达的降低。这篇叙述性综述探讨了由Th17和Th2驱动的炎症如何导致全身性炎症衰老。关键细胞因子——白细胞介素-17、白细胞介素-23、白细胞介素-4、白细胞介素-13和白细胞介素-31——促进内皮损伤、氧化应激和代谢功能障碍。我们强调血管生物标志物(如血管细胞黏附分子-1、细胞间黏附分子-1、ST2、P-选择素)和免疫细胞衰老作为衰老指标的作用。最后,我们探讨针对这些途径的生物疗法是否可能减轻炎症驱动的衰老。因此,慢性皮肤病可能成为全身性炎症衰老的易获取模型和早期干预的靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd8e/12469205/326e49d72190/cells-14-01442-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd8e/12469205/d08d76a018d0/cells-14-01442-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd8e/12469205/1fda481dc557/cells-14-01442-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd8e/12469205/326e49d72190/cells-14-01442-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd8e/12469205/d08d76a018d0/cells-14-01442-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd8e/12469205/1fda481dc557/cells-14-01442-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd8e/12469205/326e49d72190/cells-14-01442-g003.jpg

相似文献

1
Inflammation-Driven Molecular Ageing in Chronic Inflammatory Skin Diseases: Is There a Role for Biologic Therapies?慢性炎症性皮肤病中炎症驱动的分子衰老:生物疗法有作用吗?
Cells. 2025 Sep 15;14(18):1442. doi: 10.3390/cells14181442.
2
Outcome Measures for Interdisciplinary Care in Immune-mediated Inflammatory Skin Diseases (skIMIDs): A Scoping Review.免疫介导性炎症性皮肤病(skIMIDs)跨学科护理的结局指标:一项范围综述
Br J Dermatol. 2025 Apr 18. doi: 10.1093/bjd/ljaf153.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
5
[Guidelines for the prevention and management of bronchial asthma (2024 edition)].[支气管哮喘防治指南(2024年版)]
Zhonghua Jie He He Hu Xi Za Zhi. 2025 Mar 12;48(3):208-248. doi: 10.3760/cma.j.cn112147-20241013-00601.
6
Mid Forehead Brow Lift额中眉提升术
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
8
T-bet expressing Tr1 cells driven by dietary signals dominate the small intestinal immune landscape.由饮食信号驱动的表达T-bet的Tr1细胞主导小肠免疫格局。
bioRxiv. 2025 Jul 4:2025.06.30.662190. doi: 10.1101/2025.06.30.662190.
9
The roles of interleukin (IL)-17A and IL-17F in hidradenitis suppurativa pathogenesis: evidence from human in vitro preclinical experiments and clinical samples.白细胞介素(IL)-17A和IL-17F在化脓性汗腺炎发病机制中的作用:来自人体体外临床前实验和临床样本的证据
Br J Dermatol. 2025 Mar 18;192(4):660-671. doi: 10.1093/bjd/ljae442.
10
Targeting Cellular Senescence for Healthy Aging: Advances in Senolytics and Senomorphics.靶向细胞衰老以实现健康衰老:衰老细胞溶解剂和衰老细胞形态调节剂的进展
Drug Des Devel Ther. 2025 Sep 19;19:8489-8522. doi: 10.2147/DDDT.S543211. eCollection 2025.

本文引用的文献

1
Immunosenescence: signaling pathways, diseases and therapeutic targets.免疫衰老:信号通路、疾病与治疗靶点。
Signal Transduct Target Ther. 2025 Aug 6;10(1):250. doi: 10.1038/s41392-025-02371-z.
2
Effects of dupilumab on quality of life in patients with atopic dermatitis: a systematic review and meta-analysis of randomized controlled trials.度普利尤单抗对特应性皮炎患者生活质量的影响:一项随机对照试验的系统评价和荟萃分析
Front Pharmacol. 2025 Jun 10;16:1587977. doi: 10.3389/fphar.2025.1587977. eCollection 2025.
3
Effects of Adalimumab on Mitochondria of Psoriatic Mesenchymal Stem Cells.
阿达木单抗对银屑病间充质干细胞线粒体的影响。
J Cell Mol Med. 2025 Jun;29(11):e70642. doi: 10.1111/jcmm.70642.
4
The effect of IL-17 and IL-23 ınhibitors on hematological ınflammatory parameters in patients with psoriasis vulgaris.白细胞介素-17和白细胞介素-23抑制剂对寻常型银屑病患者血液学炎症参数的影响。
Ir J Med Sci. 2025 Jun 2. doi: 10.1007/s11845-025-03969-6.
5
Abrocitinib versus dupilumab: Impact on skin barrier function and proteomics in atopic dermatitis.阿布昔替尼与度普利尤单抗对比:对特应性皮炎皮肤屏障功能和蛋白质组学的影响
J Am Acad Dermatol. 2025 Aug;93(2):406-414. doi: 10.1016/j.jaad.2025.04.027. Epub 2025 Apr 15.
6
The impact of biologics targeting the IL-17 and IL-23 pathways on metabolic indicators in plaque psoriasis.靶向IL-17和IL-23通路的生物制剂对斑块状银屑病代谢指标的影响。
Arch Dermatol Res. 2025 Mar 28;317(1):643. doi: 10.1007/s00403-025-04174-2.
7
Klotho antiaging protein: molecular mechanisms and therapeutic potential in diseases.α-klotho抗衰老蛋白:疾病中的分子机制及治疗潜力
Mol Biomed. 2025 Mar 22;6(1):19. doi: 10.1186/s43556-025-00253-y.
8
High-Sensitivity CRP and Occurrence of Cancer in Cardiovascular Disease Patients with Cardiovascular.心血管疾病患者中高敏C反应蛋白与癌症发生情况
J Clin Med. 2025 Feb 12;14(4):1193. doi: 10.3390/jcm14041193.
9
The relationship between biological aging and psoriasis: evidence from three observational studies.生物衰老与银屑病之间的关系:来自三项观察性研究的证据。
Immun Ageing. 2025 Feb 11;22(1):6. doi: 10.1186/s12979-025-00500-4.
10
Dupilumab treatment restores lesional and nonlesional skin barrier function in adults and adolescents with atopic dermatitis irrespective of the filaggrin genotype: Results from an open-label, healthy-control-matched, phase 4 clinical study (BALISTAD).度普利尤单抗治疗可恢复成人和青少年特应性皮炎患者皮损及非皮损皮肤屏障功能,且与丝聚合蛋白基因型无关:一项开放标签、匹配健康对照的4期临床研究(BALISTAD)结果
J Am Acad Dermatol. 2025 May;92(5):1132-1136. doi: 10.1016/j.jaad.2024.11.079. Epub 2025 Jan 22.